Literature DB >> 33916508

Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes.

Yutaro Nakamura1, Kazutaka Mori2, Yasunori Enomoto1, Masato Kono3, Hiromitsu Sumikawa4, Takeshi Johkoh5, Thomas V Colby6, Hideki Yasui1, Hironao Hozumi1, Masato Karayama1, Yuzo Suzuki1, Kazuki Furuhashi1, Tomoyuki Fujisawa1, Noriyuki Enomoto1, Naoki Inui1,7, Yusuke Kaida8, Koshi Yokomura9, Naoki Koshimizu10, Mikio Toyoshima11, Shiro Imokawa12, Takashi Yamada13, Toshihiro Shirai14, Hidenori Nakamura3, Hiroshi Hayakawa15, Takafumi Suda1.   

Abstract

Idiopathic pleuroparenchymal fibroelastosis (PPFE) is a distinctive interstitial pneumonia with upper lobe predominance that shows unique morphological features among idiopathic interstitial pneumonias (IIPs). Affected patients have a variety of clinical presentations with heterogeneous clinical courses. Cluster analysis is a valuable tool for identifying distinct clinical phenotypes under heterogeneous conditions. This study aimed to identify the phenotypes of patients with idiopathic PPFE. Using cluster analysis, novel PPFE phenotypes were identified among subjects from our multicenter cohort, and outcomes were stratified according to phenotypic clusters. Among the subjects with baseline data (N = 84), four clusters were identified. Cluster 1 included younger male subjects with coexisting non-UIP-like patterns. Cluster 2 included elderly female nonsmokers with low body mass index (BMI). Cluster 3 included elderly male smokers with a coexisting IP-like pattern. Cluster 4 included younger male smokers without lower lobe lesions. Patients in cluster 3 had significantly worse survival outcomes than those in clusters 1, 2, and 4 (p < 0.001, p = 0.0041, and p = 0.0155, respectively). Among idiopathic PPFE patients, cluster analysis using baseline characteristics identified four distinct clinical phenotypes that might predict survival outcomes.

Entities:  

Keywords:  cluster analysis; idiopathic pleuroparenchymal fibroelastosis; prognosis

Year:  2021        PMID: 33916508     DOI: 10.3390/jcm10071498

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  3 in total

1.  Lung involvement during the prediagnostic phase of idiopathic pleuroparenchymal fibroelastosis.

Authors:  Takuto Miyamura; Yoshiaki Kinoshita; Hisako Kushima; Hiroshi Mukae; Hiroshi Ishii
Journal:  ERJ Open Res       Date:  2022-05-09

2.  Metformin reduces pleural fibroelastosis by inhibition of extracellular matrix production induced by CD90-positive myofibroblasts.

Authors:  Yoichiro Aoshima; Yasunori Enomoto; Atsuki Fukada; Yuki Kurita; Sayomi Matsushima; Shiori Meguro; Isao Kosugi; Hideya Kawasaki; Hiroaki Katsura; Tomoyuki Fujisawa; Noriyuki Enomoto; Yutaro Nakamura; Naoki Inui; Takafumi Suda; Toshihide Iwashita
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

3.  A proposed prognostic prediction score for pleuroparenchymal fibroelastosis.

Authors:  Yoshiaki Kinoshita; Takato Ikeda; Takuto Miyamura; Yusuke Ueda; Yuji Yoshida; Hisako Kushima; Masaki Fujita; Takashi Ogura; Kentaro Watanabe; Hiroshi Ishii
Journal:  Respir Res       Date:  2021-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.